Taryn Meade, our Director of Biological Evaluation Consulting, will be speaking on the “Analytical Evaluation Threshold: Practical Implementation and Regulatory Considerations”.

The North American Biocompatibility Summit (NABS) is a limited-seating event that provides industry insights and expertise sharing on the biocompatibility of medical devices. This year, sessions will include the latest regulatory updates, biological evaluation strategies and best practices that lead to successful biocompatibility programs in September 2022. 

Led by the medical device industry’s foremost biological safety experts, speakers will address:

• Regulatory strategies and how they relate to ISO 10993
• New and innovative biocompatibility methods and technologies
• The relationship between material/chemical characterization and biocompatibility testing
• Toxicology and risk management
• Industry case studies